| 000 | 01699 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514225710.0 | ||
| 264 | 0 | _c20050711 | |
| 008 | 200507s 0 0 eng d | ||
| 022 | _a1464-4096 | ||
| 024 | 7 |
_a10.1111/j.1464-410X.2005.05511.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNargund, Vinod | |
| 245 | 0 | 0 |
_aImaging with radiolabelled monoclonal antibody (MUJ591) to prostate-specific membrane antigen in staging of clinically localized prostatic carcinoma: comparison with clinical, surgical and histological staging. _h[electronic resource] |
| 260 |
_bBJU international _cJun 2005 |
||
| 300 |
_a1232-6 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xradiation effects |
| 650 | 0 | 4 |
_aAntigens, Surface _ximmunology |
| 650 | 0 | 4 |
_aGlutamate Carboxypeptidase II _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIodine Radioisotopes |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasm Staging _xmethods |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xdiagnostic imaging |
| 650 | 0 | 4 | _aRadionuclide Imaging |
| 650 | 0 | 4 | _aRadiopharmaceuticals |
| 650 | 0 | 4 | _aTechnetium |
| 650 | 0 | 4 | _aYttrium Radioisotopes |
| 700 | 1 | _aAl Hashmi, Dona | |
| 700 | 1 | _aKumar, Priya | |
| 700 | 1 | _aGordon, Stephen | |
| 700 | 1 | _aOtitie, Ugo | |
| 700 | 1 | _aEllison, David | |
| 700 | 1 | _aCarroll, Melvyn | |
| 700 | 1 | _aBaithun, Sohail | |
| 700 | 1 | _aBritton, Keith E | |
| 773 | 0 |
_tBJU international _gvol. 95 _gno. 9 _gp. 1232-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1464-410X.2005.05511.x _zAvailable from publisher's website |
| 999 |
_c15555384 _d15555384 |
||